GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...
The CDC has reduced the number of recommended childhood vaccines from 17 down to 11, according to a decision memorandum ...
Long-term Medicaid expansion was linked to substantial growth in PrEP prescribing, with earlier expansion states seeing far ...
Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...
At the 2025 AMCP annual meeting in Houston, John M. O'Brien, Pharm.D., M.P.H., president and CEO of the National ...
Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...
Primary care must ensure that patients have access to the full spectrum of preventive tools, including nutrition services, to reduce chronic conditions and avoid their associated costs.
Medications can be essential. But when paired with accessible, culturally relevant nutrition, their impact is amplified and reduces reliance on costly treatments. Investing in our patients’ long-term ...
Wayritz (rilzabrutinib) and Myqorzo (aficamten) were on the list of drugs that were expected to be approved by the FDA in the ...
At Cigna Healthcare, 2026 will be a year defined by making healthcare simpler, more affordable and more intuitive for the ...
Liraglutide, a generic of Saxenda, is approved to treat adults and adolescents who are obese or overweight. If approved, ...
Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback